Annexon Biosciences
CA - BrisbaneBiotechnology
Focus: Annexon Biosciences is a publicly traded biotech company focused on complement-mediated therapies for neurodegenerative and autoimmune disorders. The company operates at mid-cap scale with a concentrated pipeline in two Phase 3 programs targeting high-unmet-need indications.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Annexon Biosciences?
AI assessmentStrong fit for early-to-mid-career professionals seeking regulatory and clinical exposure at a capital-efficient biotech, but limited hiring velocity and pre-revenue status warrant cash runway due diligence.
Why Work Here
- Two Phase 3 programs (ANX005 in Guillain-Barré Syndrome, ANX007 in Geographic Atrophy) represent near-term regulatory catalysts and potential pathway to profitability.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data F
Age Related Macular Degeneration (AMD)Clinical Trials (1)
NCT07424235Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort
N/AHelp build intelligence for Annexon Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.